Kidney News and Research

RSS

Electrolyte abnormalities in eating disorders associated with higher risk of death from any cause

A new study published in The Lancet Psychiatry found that 32% of individuals with an eating disorder had abnormal electrolyte levels, which were associated with a higher risk of death from any cause.

18 Sep 2024

Study links diabetes drugs to lower risk of dementia and Parkinson's disease

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

18 Sep 2024

Study paves way for revolutionizing the management of muscle disorders

The type 1 ryanodine receptor (RyR1) is an important calcium release channel in skeletal muscles essential for muscle contraction.

18 Sep 2024

New insights into the mechanisms of efavirenz-induced neurotoxicity

Efavirenz is an important drug for treating HIV infection, but it has negative effects that can significantly impact patients' quality of life over time. It causes neuropsychiatric disorders and neurocognitive impairment in roughly 50 percent of patients. The drug is associated with abnormal lipid levels in blood plasma, but the molecular mechanisms responsible for negative clinical observations are unknown.

18 Sep 2024

Lupus Research Alliance announces 2024 Diversity in Lupus Research Award recipients

The Lupus Research Alliance (LRA) is pleased to announce the recipients of the 2024 Career Development and Postdoctoral Awards to Promote Diversity in Lupus Research.

17 Sep 2024

Assessing the impact of weight loss and blood sugar control in people with type 2 diabetes

A Cleveland Clinic research team has published the first study assessing the independent real-world impacts of weight loss and blood sugar control on clinical outcomes in people with type 2 diabetes treated with antidiabetic medications, and specifically with GLP-1RAs (the class of drug that includes Ozempic and Wegovy).

17 Sep 2024

Loneliness may not be a direct cause of disease

A study reveals loneliness correlates with 13 illness categories, highlighting its role as a potential proxy marker rather than a direct risk factor.

17 Sep 2024

Cancer patients face increased risk of long-term mental health problems

People diagnosed with cancer are at a greater risk of mental health problems even five years after their diagnosis, according to a large-scale study of data from UK GP patient records.

17 Sep 2024

Newcells Biotech launches high-content and high-throughput imaging suite to advance pre-clinical drug development programmes

Newcells Biotech (“Newcells”), a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, today announced the launch of its imaging suite and advanced lung Fibroblast-to-Myofibroblast Transition (FMT) assay.

From Newcells Biotech 17 Sep 2024

Breakthrough metabolomic aging score that predicts mortality better than traditional methods

Researchers developed a metabolomic aging score using NMR biomarkers that predicts short-term mortality and disease risk more accurately than other aging metrics.

16 Sep 2024

Family member’s cancer diagnosis may increase risks of psychological and cardiovascular illnesses

New research suggests that a family member’s cancer diagnosis may increase first-degree relatives’ and spouses’ risks of developing psychological and cardiovascular illnesses.

16 Sep 2024

Scientists develop novel technique to combat T cell exhaustion

Fighting cancer is exhausting for T cells. Hostile tumor microenvironments can drain their mitochondrial activity, leading to a condition known as T cell exhaustion. This phenomenon also hinders adoptive cell therapies, in which healthy, tumor-targeting T cells are infused into patients with cancer. A novel method to boost mitochondrial activity and charge up T cells is needed.

14 Sep 2024

Study reveals how SARS-CoV-2 triggers diabetes by destroying pancreatic cells

Researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the mechanism by which SARS-CoV-2, the virus that causes COVID-19, induces new cases of diabetes, and worsens complications in people who already have it.

13 Sep 2024

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) has found.

13 Sep 2024

PPARs and PROTACs: A new strategy in cancer therapeutics

The growing challenge in cancer therapy lies in overcoming tumor heterogeneity, drug resistance, and associated side effects.

13 Sep 2024

Advanced insulin pump technology improves diabetes management for marathon runners

A series of case reports to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept), describe how a technology giving insulin doses informed by an insulin pump algorithm helped three adults with type 1 diabetes better manage their blood sugars enabling them to lead more active lives, and even run marathons.

13 Sep 2024

Trial finds no benefit of adding nivolumab to tivozanib for advanced kidney cancer

In an international multicenter randomized phase 3 clinical trial led by Dana-Farber Cancer Institute, researchers tested the addition of the immune checkpoint inhibitor (ICI) nivolumab to treatment with tivozanib for patients with advanced clear cell renal cell carcinoma, a form of kidney cancer.

13 Sep 2024

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don't have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

13 Sep 2024

Cancer cases in the US continued to be underdiagnosed during the second year of the COVID-19 pandemic

Researchers examine how the COVID-19 pandemic affected cancer diagnosis rates between 2021 and 2020.

13 Sep 2024

Five key factors identified for predicting immunotherapy response in cancer patients

Immunotherapy has transformed cancer treatment in recent years by enabling the immune system to attack tumor cells.

12 Sep 2024

Kidney News and Research

Electrolyte abnormalities in eating disorders associated with higher risk of death from any cause

Study links diabetes drugs to lower risk of dementia and Parkinson's disease

Study paves way for revolutionizing the management of muscle disorders

New insights into the mechanisms of efavirenz-induced neurotoxicity

Lupus Research Alliance announces 2024 Diversity in Lupus Research Award recipients

Assessing the impact of weight loss and blood sugar control in people with type 2 diabetes

Loneliness may not be a direct cause of disease

Cancer patients face increased risk of long-term mental health problems

Newcells Biotech launches high-content and high-throughput imaging suite to advance pre-clinical drug development programmes

Breakthrough metabolomic aging score that predicts mortality better than traditional methods

Family member’s cancer diagnosis may increase risks of psychological and cardiovascular illnesses

Scientists develop novel technique to combat T cell exhaustion

Study reveals how SARS-CoV-2 triggers diabetes by destroying pancreatic cells

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

PPARs and PROTACs: A new strategy in cancer therapeutics

Advanced insulin pump technology improves diabetes management for marathon runners

Trial finds no benefit of adding nivolumab to tivozanib for advanced kidney cancer

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

Cancer cases in the US continued to be underdiagnosed during the second year of the COVID-19 pandemic

Five key factors identified for predicting immunotherapy response in cancer patients

Event guide: 8th CKD Summit 2026 eBook

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News